[Management of the carotid artery stenosis]

Sébastien Déglise1, Céline Dubuis, Pascal Mosimann

  • 1Service de Chirurgie Thoracique et Vasculaire Division de Chirurgie Vasculaire, CHUV, Lausanne. sebastien.deglise@chuv.ch

Revue Medicale Suisse
|July 24, 2013
PubMed

Insights

Carotid artery stenosis is a leading cause of stroke in older adults. Treatment options include surgery and stenting, with best medical treatment reducing stroke rates and limiting interventions.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Cardiology

Context:

  • Carotid artery stenosis is a significant risk factor for ischemic stroke, particularly in elderly populations.
  • Symptomatic stenosis exceeding 50% within two weeks necessitates therapeutic intervention.
  • Advances in medical treatment have altered the landscape of managing carotid stenosis.

Purpose:

  • To review the therapeutic indications and treatment options for carotid artery stenosis.
  • To compare the efficacy and risks of carotid endarterectomy versus carotid stenting.
  • To highlight the role of best medical treatment in managing carotid stenosis and preventing stroke.

Summary:

  • Carotid endarterectomy is the preferred surgical approach for symptomatic stenosis (>50%), offering superior outcomes compared to stenting in most patients.
  • Carotid stenting is a viable alternative for patients at high surgical risk, despite a higher post-operative stroke and death rate.
  • Comprehensive medical management, including risk factor modification, statins, and antiplatelet therapy, has drastically reduced stroke incidence.
  • Intervention for asymptomatic stenosis is now limited to specific high-risk individuals (e.g., men with >70% stenosis and 5-year life expectancy).

Impact:

  • Optimized treatment strategies for carotid artery stenosis can significantly reduce the incidence of ischemic stroke.
  • Risk stratification is crucial for selecting the most appropriate intervention (surgery, stenting, or medical management).
  • The evolution of medical therapy has decreased the need for invasive procedures in certain patient groups, improving overall patient outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...